Cooperative Agreement HR0011262E008
- The University of Melbourne was awarded a $591,778 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Harnessing the Immune Response in Exceptionally Long-Term Survivors to Develop Novel Therapeutics." The project will run from May 1, 2024 to April 30, 2027. The University of Melbourne has a history of conducting federal research and consulting work in areas such as...
- The University of Melbourne was awarded a $721,656 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the minimally-invasive measurement of pressure dynamics in the brain following traumatic brain injury. The award has a period of performance from November 1, 2025 to October 31, 2028. The University of Melbourne is an established international research institution with expertise in advanced biomedical...
- The University of Chicago was awarded a $3,036,943 Cooperative Agreement from the Defense Advanced Research Projects Agency (DARPA) under the Research and Technology Development program (CFDA 12.910). This 30-month base effort, awarded on July 28, 2025, supports the university's research and development of revolutionary advances in areas such as quantum technologies, artificial intelligence, biotechnology, advanced materials, and sensing capabilities. The award aims to drive transformative...
- This $742,000 cooperative agreement was awarded by the Defense Advanced Research Projects Agency (DARPA) under the Research and Technology Development program (CFDA 12.910) to Carnegie Mellon University (CMU) for the "COASTERCHASE PROGRAM". The 24-month project, running from January 1, 2026 to December 31, 2027, will involve CMU's Office of Sponsored Programs Division conducting advanced research and technology development in areas relevant to national security. As a renowned private...
- This federal Project Grant award in the amount of $733,068.00 was issued by the Defense Health Agency to the University of Melbourne on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project titled "Investigating Transcript Diversity as a Driver of Melanoma Progression and Recurrence." The University of Melbourne will conduct basic, translational, and clinical research aimed at developing new...
- The University of Chicago was awarded a $572,926 Cooperative Agreement by the Defense Advanced Research Projects Agency (DARPA) under the Research and Technology Development program (CFDA 12.910) to conduct research supporting DARPA's Mechanically Interlocked Materials (MIMs) program. The effort involves the scalable synthesis of poly N-catenane and interlocked polymer networks, as described in the university's research proposal. The award began on September 28, 2023 and is scheduled for...
- The Defense Advanced Research Projects Agency (DARPA), through its Research and Technology Development program (CFDA 12.910), awarded a $150,000 cooperative agreement to the Regents of the University of Michigan to conduct innovative research on enabling revolutionary advances in mmWave array systems. The research will investigate innovative approaches to address key challenges around array-wide synchronization and aiming, which have limited the potential for compact mmWave arrays with massive...
- The University of Michigan was awarded a $250,000 Project Grant from the Defense Advanced Research Projects Agency (DARPA) under the Research and Technology Development program (CFDA 12.910). The grant will support basic, applied, and advanced research at the University from September 2021 through September 2023 that may have military or dual-use applications. As the place of performance is listed as Michigan, it can be inferred the research will be conducted at the University's campus location....
- The U.S. Defense Advanced Research Projects Agency (DARPA) awarded a $704,191 Cooperative Agreement to The Trustees of Princeton University on June 25, 2025, with a completion date of December 25, 2026. This award was provided under DARPA's Research and Technology Development program (CFDA 12.910), which supports innovative, high-risk, high-reward research across diverse scientific and technological domains. Through this Cooperative Agreement, Princeton University will conduct research and...
- The Defense Advanced Research Projects Agency (DARPA) awarded a $841,492 Cooperative Agreement to the Massachusetts Institute of Technology (MIT) under the Research and Technology Development program (CFDA 12.910) on April 22, 2025. The purpose of this modification is to provide $235,171 in FY26 incremental funding and revise the cognizant Grants Officer. The Cooperative Agreement supports MIT's ongoing research and development of innovative, high-risk, high-reward technologies with potential...
The University of Melbourne was awarded a $821,000.00 Cooperative Agreement by the Defense Advanced Research Projects Agency (DARPA) under the Research and Technology Development program (CFDA 12.910). The 24-month award, beginning on January 1, 2026 and ending on December 31, 2027, will support the university's advanced research and technology development in the COASTERCHASE program. The university, a prominent international research institution located in Australia, has a demonstrated history of conducting sophisticated scientific investigations across multiple domains, including medical research, biotechnology, and aerospace engineering. Through this DARPA award, the University of Melbourne will leverage its expertise to deliver transformative research and technological innovations with potential national security applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $821.0k | 12/16/25 |